Drug study

Drug study
16問 • 1年前
  • JULLIANNE DANDAN
  • 通報

    問題一覧

  • 1

    Classification: Antiviral, antiparkinsonian agent. Mechanism of Action: Inhibits M2 ion channels of the influenza virus; increases dopamine release and inhibits reuptake in the CNS, acting as an NMDA receptor antagonist. Indications: Primarily for Parkinson’s disease and drug-induced extrapyramidal symptoms; also used for fatigue in multiple sclerosis and postherpetic neuralgia. Contraindications: Congestive heart failure, hypersensitivity, active bleeding disorders. Adverse Reactions: Dizziness, insomnia, hallucinations, peripheral edema, and potential for seizures. Nursing Responsibilities: Monitor for adverse effects, assess renal function, educate on risks of abrupt withdrawal, and evaluate effectiveness over time.

    Amantadine

  • 2

    Classification: Antiparkinsonian agent. Mechanism of Action: Levodopa converts to dopamine in the brain; carbidopa prevents levodopa conversion to dopamine outside the CNS, enhancing its availability in the brain. Indications: Treatment of Parkinson’s disease symptoms such as bradykinesia, rigidity, and tremor. Contraindications: Narrow-angle glaucoma, melanoma, and non-selective MAO inhibitors. Adverse Reactions: Nausea, vomiting, orthostatic hypotension, dyskinesias. Nursing Responsibilities: Monitor for effectiveness and side effects; educate patients on potential interactions and dietary considerations.

    Carbidopa-Levodopa

  • 3

    Classification: Antiparkinsonian agent. Mechanism of Action: Converts to dopamine in the CNS to alleviate Parkinson’s symptoms. Indications: Primary treatment for Parkinson’s disease; effective for bradykinesia and rigidity. Contraindications: Hypersensitivity to levodopa or carbidopa; narrow-angle glaucoma. Adverse Reactions: Nausea, dizziness, dyskinesias, and orthostatic hypotension. Nursing Responsibilities: Monitor vital signs and neurological status; assess for medication effectiveness and side effects.

    Levodopa

  • 4

    Classification: Anticonvulsant. Mechanism of Action: Stabilizes neuronal membranes by inhibiting sodium channels, reducing excitability. Indications: Treatment of epilepsy, trigeminal neuralgia, and bipolar disorder. Contraindications: Hypersensitivity to carbamazepine or tricyclic antidepressants; bone marrow suppression. Adverse Reactions: Dizziness, drowsiness, nausea, and potential agranulocytosis. Nursing Responsibilities: Monitor CBC for blood dyscrasias; educate about potential interactions with other medications.

    Carbamazepine

  • 5

    Classification: Anticonvulsant. Mechanism of Action: Inhibits sodium channels and modulates glutamate release to stabilize neuronal activity. Indications: Epilepsy (partial seizures) and bipolar disorder maintenance therapy. Contraindications: Hypersensitivity to lamotrigine; history of rash with lamotrigine use. Adverse Reactions: Rash (risk of Stevens-Johnson syndrome), dizziness, headache. Nursing Responsibilities: Monitor skin for rashes; titrate dosage carefully to minimize side effects.

    Lamotrigine

  • 6

    Classification: Barbiturate anticonvulsant. Mechanism of Action: Enhances GABA activity at GABA-A receptors to produce sedation and anticonvulsant effects. Indications: Seizure disorders (tonic-clonic seizures) and as a sedative-hypnotic agent. Contraindications: Severe respiratory disease or history of substance abuse disorders. Adverse Reactions: Sedation, dizziness, cognitive impairment, respiratory depression. Nursing Responsibilities: Monitor respiratory status; assess sedation levels and educate about potential dependency risks.

    Phenobarbital

  • 7

    Classification: Benzodiazepine. Mechanism of Action: Enhances GABA-A receptor activity leading to increased inhibitory neurotransmission in the CNS. Indications: Anxiety disorders, panic disorders, seizure disorders (including absence seizures). Contraindications: Severe respiratory insufficiency or sleep apnea syndrome; hypersensitivity to benzodiazepines. Adverse Reactions: Drowsiness, dizziness, confusion, dependence risk with long-term use. Nursing Responsibilities: Monitor for sedation levels; educate about potential withdrawal symptoms upon discontinuation.

    Clonazepam

  • 8

    Classification: Benzodiazepine. Mechanism of Action: Enhances GABA-A receptor activity resulting in anxiolytic effects and muscle relaxation. Indications: Anxiety relief, muscle spasms, seizures; also used for sedation prior to procedures. Contraindications: Severe respiratory insufficiency or acute narrow-angle glaucoma; hypersensitivity to diazepam or other benzodiazepines. Adverse Reactions: Drowsiness, fatigue, ataxia; risk of dependence with prolonged use. Nursing Responsibilities: Monitor vital signs during administration; assess for signs of misuse or dependence.

    Diazepam

  • 9

    Classification: Anticholinergic antiparkinsonian agent. Mechanism of Action: Blocks acetylcholine receptors in the CNS to reduce tremors and rigidity associated with Parkinson’s disease or drug-induced extrapyramidal symptoms. Indications: Parkinson’s disease management and acute dystonic reactions from antipsychotics . Contraindications: Narrow-angle glaucoma and prostatic hypertrophy . Adverse Reactions: Dry mouth, constipation, urinary retention . Nursing Responsibilities: Monitor for anticholinergic side effects; educate patients on hydration needs .

    Benztropine

  • 10

    Classification: Antihistamine. Mechanism of Action: Competes with histamine at H1 receptor sites to reduce allergy symptoms . Indications: Allergic reactions, motion sickness prevention, insomnia . Contraindications: Acute asthma attacks and hypersensitivity to diphenhydramine . Adverse Reactions: Drowsiness, dry mouth, blurred vision . Nursing Responsibilities: Assess sedation levels; advise against operating heavy machinery until effects are known .

    Diphenhydramine

  • 11

    Classification: Anticholinergic antiparkinsonian agent. Mechanism of Action: Reduces cholinergic activity in the CNS to alleviate tremors associated with Parkinson’s disease . Indications: Management of parkinsonian symptoms and drug-induced extrapyramidal symptoms . Contraindications: Glaucoma and myasthenia gravis . Adverse Reactions: Dry mouth, constipation, urinary retention . Nursing Responsibilities: Monitor for anticholinergic side effects; educate on dosage adjustments if adverse reactions occur .

    Trihexyphenidyl

  • 12

    Classification: Selective serotonin reuptake inhibitor (SSRI). Mechanism of Action: Inhibits serotonin reuptake in the brain to enhance mood regulation . Indications: Major depressive disorder, anxiety disorders (including OCD), PTSD . Contraindications: Concurrent use with MAO inhibitors or hypersensitivity to sertraline . Adverse Reactions: Nausea, insomnia, sexual dysfunction . Nursing Responsibilities: Monitor mood changes and suicidal ideation; assess for serotonin syndrome symptoms during treatment initiation .

    Sertraline

  • 13

    is a progressive neurological disorder characterized by the degeneration of dopamine-producing neurons in the brain, leading to movement and mood disturbances.

    Parkinson’s disease

  • 14

    Parkinson’s disease: Typically starting in one hand or arm.

    Tremors

  • 15

    Parkinson’s disease: Slowed movements affecting daily tasks.

    Bradykinesia

  • 16

    Parkinson’s disease: Muscle stiffness impacting mobility and posture

    Rigidity

  • Latin Abbreviations

    Latin Abbreviations

    JULLIANNE DANDAN · 43問 · 2年前

    Latin Abbreviations

    Latin Abbreviations

    43問 • 2年前
    JULLIANNE DANDAN

    History Taking

    History Taking

    JULLIANNE DANDAN · 11問 · 2年前

    History Taking

    History Taking

    11問 • 2年前
    JULLIANNE DANDAN

    Skin Assessment

    Skin Assessment

    JULLIANNE DANDAN · 8問 · 2年前

    Skin Assessment

    Skin Assessment

    8問 • 2年前
    JULLIANNE DANDAN

    Positioning the Patient for different Examinations

    Positioning the Patient for different Examinations

    JULLIANNE DANDAN · 32問 · 2年前

    Positioning the Patient for different Examinations

    Positioning the Patient for different Examinations

    32問 • 2年前
    JULLIANNE DANDAN

    Body Mechanics

    Body Mechanics

    JULLIANNE DANDAN · 22問 · 2年前

    Body Mechanics

    Body Mechanics

    22問 • 2年前
    JULLIANNE DANDAN

    Moving and Transferring Patient

    Moving and Transferring Patient

    JULLIANNE DANDAN · 5問 · 2年前

    Moving and Transferring Patient

    Moving and Transferring Patient

    5問 • 2年前
    JULLIANNE DANDAN

    Self Efficacy Theory

    Self Efficacy Theory

    JULLIANNE DANDAN · 11問 · 2年前

    Self Efficacy Theory

    Self Efficacy Theory

    11問 • 2年前
    JULLIANNE DANDAN

    HEALTH BELIEF MODEL

    HEALTH BELIEF MODEL

    JULLIANNE DANDAN · 13問 · 2年前

    HEALTH BELIEF MODEL

    HEALTH BELIEF MODEL

    13問 • 2年前
    JULLIANNE DANDAN

    HEALTH PROMOTION MODEL

    HEALTH PROMOTION MODEL

    JULLIANNE DANDAN · 8問 · 2年前

    HEALTH PROMOTION MODEL

    HEALTH PROMOTION MODEL

    8問 • 2年前
    JULLIANNE DANDAN

    Preceed Proceed Model

    Preceed Proceed Model

    JULLIANNE DANDAN · 11問 · 2年前

    Preceed Proceed Model

    Preceed Proceed Model

    11問 • 2年前
    JULLIANNE DANDAN

    Modes of Communication

    Modes of Communication

    JULLIANNE DANDAN · 10問 · 2年前

    Modes of Communication

    Modes of Communication

    10問 • 2年前
    JULLIANNE DANDAN

    Communication and Globalization

    Communication and Globalization

    JULLIANNE DANDAN · 16問 · 2年前

    Communication and Globalization

    Communication and Globalization

    16問 • 2年前
    JULLIANNE DANDAN

    Intercultural Communication

    Intercultural Communication

    JULLIANNE DANDAN · 14問 · 2年前

    Intercultural Communication

    Intercultural Communication

    14問 • 2年前
    JULLIANNE DANDAN

    The Cultural Texts

    The Cultural Texts

    JULLIANNE DANDAN · 7問 · 2年前

    The Cultural Texts

    The Cultural Texts

    7問 • 2年前
    JULLIANNE DANDAN

    The Communication Process

    The Communication Process

    JULLIANNE DANDAN · 25問 · 2年前

    The Communication Process

    The Communication Process

    25問 • 2年前
    JULLIANNE DANDAN

    Lecture 1 and 2

    Lecture 1 and 2

    JULLIANNE DANDAN · 87問 · 2年前

    Lecture 1 and 2

    Lecture 1 and 2

    87問 • 2年前
    JULLIANNE DANDAN

    Lecture 3

    Lecture 3

    JULLIANNE DANDAN · 48問 · 2年前

    Lecture 3

    Lecture 3

    48問 • 2年前
    JULLIANNE DANDAN

    Lecture 4 and Microflora

    Lecture 4 and Microflora

    JULLIANNE DANDAN · 89問 · 2年前

    Lecture 4 and Microflora

    Lecture 4 and Microflora

    89問 • 2年前
    JULLIANNE DANDAN

    Lecture 1 & 2

    Lecture 1 & 2

    JULLIANNE DANDAN · 11問 · 2年前

    Lecture 1 & 2

    Lecture 1 & 2

    11問 • 2年前
    JULLIANNE DANDAN

    LEARNING andthe LEARNER

    LEARNING andthe LEARNER

    JULLIANNE DANDAN · 16問 · 2年前

    LEARNING andthe LEARNER

    LEARNING andthe LEARNER

    16問 • 2年前
    JULLIANNE DANDAN

    NURSING AS A PROFESSION

    NURSING AS A PROFESSION

    JULLIANNE DANDAN · 15問 · 2年前

    NURSING AS A PROFESSION

    NURSING AS A PROFESSION

    15問 • 2年前
    JULLIANNE DANDAN

    Barbara Carper & Patricia Benner

    Barbara Carper & Patricia Benner

    JULLIANNE DANDAN · 12問 · 2年前

    Barbara Carper & Patricia Benner

    Barbara Carper & Patricia Benner

    12問 • 2年前
    JULLIANNE DANDAN

    Legal Aspects of Nursing

    Legal Aspects of Nursing

    JULLIANNE DANDAN · 33問 · 2年前

    Legal Aspects of Nursing

    Legal Aspects of Nursing

    33問 • 2年前
    JULLIANNE DANDAN

    Nursing as a Profession

    Nursing as a Profession

    JULLIANNE DANDAN · 41問 · 2年前

    Nursing as a Profession

    Nursing as a Profession

    41問 • 2年前
    JULLIANNE DANDAN

    OVERVIEW OF THE CODE OF ETHICS FOR NURSES

    OVERVIEW OF THE CODE OF ETHICS FOR NURSES

    JULLIANNE DANDAN · 26問 · 2年前

    OVERVIEW OF THE CODE OF ETHICS FOR NURSES

    OVERVIEW OF THE CODE OF ETHICS FOR NURSES

    26問 • 2年前
    JULLIANNE DANDAN

    GLOBAL EVOLUTION/HISTORY OF NURSING

    GLOBAL EVOLUTION/HISTORY OF NURSING

    JULLIANNE DANDAN · 93問 · 2年前

    GLOBAL EVOLUTION/HISTORY OF NURSING

    GLOBAL EVOLUTION/HISTORY OF NURSING

    93問 • 2年前
    JULLIANNE DANDAN

    Thorax and Lungs (Respiratory Assessment)

    Thorax and Lungs (Respiratory Assessment)

    JULLIANNE DANDAN · 14問 · 2年前

    Thorax and Lungs (Respiratory Assessment)

    Thorax and Lungs (Respiratory Assessment)

    14問 • 2年前
    JULLIANNE DANDAN

    Bed Bath

    Bed Bath

    JULLIANNE DANDAN · 6問 · 2年前

    Bed Bath

    Bed Bath

    6問 • 2年前
    JULLIANNE DANDAN

    Gastrointestinal

    Gastrointestinal

    JULLIANNE DANDAN · 47問 · 2年前

    Gastrointestinal

    Gastrointestinal

    47問 • 2年前
    JULLIANNE DANDAN

    Cardio

    Cardio

    JULLIANNE DANDAN · 31問 · 2年前

    Cardio

    Cardio

    31問 • 2年前
    JULLIANNE DANDAN

    COMMUNICATION

    COMMUNICATION

    JULLIANNE DANDAN · 65問 · 2年前

    COMMUNICATION

    COMMUNICATION

    65問 • 2年前
    JULLIANNE DANDAN

    COMMON COMMUNICATION STRATEGIES/TECHNIQUES (Therapeutic Communication Techniques)

    COMMON COMMUNICATION STRATEGIES/TECHNIQUES (Therapeutic Communication Techniques)

    JULLIANNE DANDAN · 17問 · 2年前

    COMMON COMMUNICATION STRATEGIES/TECHNIQUES (Therapeutic Communication Techniques)

    COMMON COMMUNICATION STRATEGIES/TECHNIQUES (Therapeutic Communication Techniques)

    17問 • 2年前
    JULLIANNE DANDAN

    MAN

    MAN

    JULLIANNE DANDAN · 10問 · 2年前

    MAN

    MAN

    10問 • 2年前
    JULLIANNE DANDAN

    PRE-NATAL CARE AND ASSESSMENT

    PRE-NATAL CARE AND ASSESSMENT

    JULLIANNE DANDAN · 94問 · 1年前

    PRE-NATAL CARE AND ASSESSMENT

    PRE-NATAL CARE AND ASSESSMENT

    94問 • 1年前
    JULLIANNE DANDAN

    DRUG ADMINISTRATION

    DRUG ADMINISTRATION

    JULLIANNE DANDAN · 17問 · 1年前

    DRUG ADMINISTRATION

    DRUG ADMINISTRATION

    17問 • 1年前
    JULLIANNE DANDAN

    Antepartum / Prenatal Assessment

    Antepartum / Prenatal Assessment

    JULLIANNE DANDAN · 32問 · 1年前

    Antepartum / Prenatal Assessment

    Antepartum / Prenatal Assessment

    32問 • 1年前
    JULLIANNE DANDAN

    Diagnostic and Laboratory Tests in Pregnancy

    Diagnostic and Laboratory Tests in Pregnancy

    JULLIANNE DANDAN · 8問 · 1年前

    Diagnostic and Laboratory Tests in Pregnancy

    Diagnostic and Laboratory Tests in Pregnancy

    8問 • 1年前
    JULLIANNE DANDAN

    Nursing Care During Prenatal Period:Positioning, Draping, Enema & Catheterization

    Nursing Care During Prenatal Period:Positioning, Draping, Enema & Catheterization

    JULLIANNE DANDAN · 14問 · 1年前

    Nursing Care During Prenatal Period:Positioning, Draping, Enema & Catheterization

    Nursing Care During Prenatal Period:Positioning, Draping, Enema & Catheterization

    14問 • 1年前
    JULLIANNE DANDAN

    Labor

    Labor

    JULLIANNE DANDAN · 73問 · 1年前

    Labor

    Labor

    73問 • 1年前
    JULLIANNE DANDAN

    Carbohydrate

    Carbohydrate

    JULLIANNE DANDAN · 26問 · 1年前

    Carbohydrate

    Carbohydrate

    26問 • 1年前
    JULLIANNE DANDAN

    FATS

    FATS

    JULLIANNE DANDAN · 26問 · 1年前

    FATS

    FATS

    26問 • 1年前
    JULLIANNE DANDAN

    Vitamins and Minerals

    Vitamins and Minerals

    JULLIANNE DANDAN · 32問 · 1年前

    Vitamins and Minerals

    Vitamins and Minerals

    32問 • 1年前
    JULLIANNE DANDAN

    Nutrition and Diet

    Nutrition and Diet

    JULLIANNE DANDAN · 23問 · 1年前

    Nutrition and Diet

    Nutrition and Diet

    23問 • 1年前
    JULLIANNE DANDAN

    WEEK 2

    WEEK 2

    JULLIANNE DANDAN · 27問 · 1年前

    WEEK 2

    WEEK 2

    27問 • 1年前
    JULLIANNE DANDAN

    Week 3

    Week 3

    JULLIANNE DANDAN · 40問 · 1年前

    Week 3

    Week 3

    40問 • 1年前
    JULLIANNE DANDAN

    Week 5

    Week 5

    JULLIANNE DANDAN · 8問 · 1年前

    Week 5

    Week 5

    8問 • 1年前
    JULLIANNE DANDAN

    Chapter 1

    Chapter 1

    JULLIANNE DANDAN · 18問 · 1年前

    Chapter 1

    Chapter 1

    18問 • 1年前
    JULLIANNE DANDAN

    Chapter 2

    Chapter 2

    JULLIANNE DANDAN · 11問 · 1年前

    Chapter 2

    Chapter 2

    11問 • 1年前
    JULLIANNE DANDAN

    Week 7

    Week 7

    JULLIANNE DANDAN · 35問 · 1年前

    Week 7

    Week 7

    35問 • 1年前
    JULLIANNE DANDAN

    NUTRITION-AND-THE-LIFE-CYCLE-LEC-AND-LAB

    NUTRITION-AND-THE-LIFE-CYCLE-LEC-AND-LAB

    JULLIANNE DANDAN · 56問 · 1年前

    NUTRITION-AND-THE-LIFE-CYCLE-LEC-AND-LAB

    NUTRITION-AND-THE-LIFE-CYCLE-LEC-AND-LAB

    56問 • 1年前
    JULLIANNE DANDAN

    THERAPEUTIC DIET

    THERAPEUTIC DIET

    JULLIANNE DANDAN · 21問 · 1年前

    THERAPEUTIC DIET

    THERAPEUTIC DIET

    21問 • 1年前
    JULLIANNE DANDAN

    VITAMINS AND MINERALS

    VITAMINS AND MINERALS

    JULLIANNE DANDAN · 31問 · 1年前

    VITAMINS AND MINERALS

    VITAMINS AND MINERALS

    31問 • 1年前
    JULLIANNE DANDAN

    Week 7

    Week 7

    JULLIANNE DANDAN · 30問 · 1年前

    Week 7

    Week 7

    30問 • 1年前
    JULLIANNE DANDAN

    Week 8 and 9

    Week 8 and 9

    JULLIANNE DANDAN · 86問 · 1年前

    Week 8 and 9

    Week 8 and 9

    86問 • 1年前
    JULLIANNE DANDAN

    Week 10

    Week 10

    JULLIANNE DANDAN · 17問 · 1年前

    Week 10

    Week 10

    17問 • 1年前
    JULLIANNE DANDAN

    Abbreviations

    Abbreviations

    JULLIANNE DANDAN · 13問 · 1年前

    Abbreviations

    Abbreviations

    13問 • 1年前
    JULLIANNE DANDAN

    問題一覧

  • 1

    Classification: Antiviral, antiparkinsonian agent. Mechanism of Action: Inhibits M2 ion channels of the influenza virus; increases dopamine release and inhibits reuptake in the CNS, acting as an NMDA receptor antagonist. Indications: Primarily for Parkinson’s disease and drug-induced extrapyramidal symptoms; also used for fatigue in multiple sclerosis and postherpetic neuralgia. Contraindications: Congestive heart failure, hypersensitivity, active bleeding disorders. Adverse Reactions: Dizziness, insomnia, hallucinations, peripheral edema, and potential for seizures. Nursing Responsibilities: Monitor for adverse effects, assess renal function, educate on risks of abrupt withdrawal, and evaluate effectiveness over time.

    Amantadine

  • 2

    Classification: Antiparkinsonian agent. Mechanism of Action: Levodopa converts to dopamine in the brain; carbidopa prevents levodopa conversion to dopamine outside the CNS, enhancing its availability in the brain. Indications: Treatment of Parkinson’s disease symptoms such as bradykinesia, rigidity, and tremor. Contraindications: Narrow-angle glaucoma, melanoma, and non-selective MAO inhibitors. Adverse Reactions: Nausea, vomiting, orthostatic hypotension, dyskinesias. Nursing Responsibilities: Monitor for effectiveness and side effects; educate patients on potential interactions and dietary considerations.

    Carbidopa-Levodopa

  • 3

    Classification: Antiparkinsonian agent. Mechanism of Action: Converts to dopamine in the CNS to alleviate Parkinson’s symptoms. Indications: Primary treatment for Parkinson’s disease; effective for bradykinesia and rigidity. Contraindications: Hypersensitivity to levodopa or carbidopa; narrow-angle glaucoma. Adverse Reactions: Nausea, dizziness, dyskinesias, and orthostatic hypotension. Nursing Responsibilities: Monitor vital signs and neurological status; assess for medication effectiveness and side effects.

    Levodopa

  • 4

    Classification: Anticonvulsant. Mechanism of Action: Stabilizes neuronal membranes by inhibiting sodium channels, reducing excitability. Indications: Treatment of epilepsy, trigeminal neuralgia, and bipolar disorder. Contraindications: Hypersensitivity to carbamazepine or tricyclic antidepressants; bone marrow suppression. Adverse Reactions: Dizziness, drowsiness, nausea, and potential agranulocytosis. Nursing Responsibilities: Monitor CBC for blood dyscrasias; educate about potential interactions with other medications.

    Carbamazepine

  • 5

    Classification: Anticonvulsant. Mechanism of Action: Inhibits sodium channels and modulates glutamate release to stabilize neuronal activity. Indications: Epilepsy (partial seizures) and bipolar disorder maintenance therapy. Contraindications: Hypersensitivity to lamotrigine; history of rash with lamotrigine use. Adverse Reactions: Rash (risk of Stevens-Johnson syndrome), dizziness, headache. Nursing Responsibilities: Monitor skin for rashes; titrate dosage carefully to minimize side effects.

    Lamotrigine

  • 6

    Classification: Barbiturate anticonvulsant. Mechanism of Action: Enhances GABA activity at GABA-A receptors to produce sedation and anticonvulsant effects. Indications: Seizure disorders (tonic-clonic seizures) and as a sedative-hypnotic agent. Contraindications: Severe respiratory disease or history of substance abuse disorders. Adverse Reactions: Sedation, dizziness, cognitive impairment, respiratory depression. Nursing Responsibilities: Monitor respiratory status; assess sedation levels and educate about potential dependency risks.

    Phenobarbital

  • 7

    Classification: Benzodiazepine. Mechanism of Action: Enhances GABA-A receptor activity leading to increased inhibitory neurotransmission in the CNS. Indications: Anxiety disorders, panic disorders, seizure disorders (including absence seizures). Contraindications: Severe respiratory insufficiency or sleep apnea syndrome; hypersensitivity to benzodiazepines. Adverse Reactions: Drowsiness, dizziness, confusion, dependence risk with long-term use. Nursing Responsibilities: Monitor for sedation levels; educate about potential withdrawal symptoms upon discontinuation.

    Clonazepam

  • 8

    Classification: Benzodiazepine. Mechanism of Action: Enhances GABA-A receptor activity resulting in anxiolytic effects and muscle relaxation. Indications: Anxiety relief, muscle spasms, seizures; also used for sedation prior to procedures. Contraindications: Severe respiratory insufficiency or acute narrow-angle glaucoma; hypersensitivity to diazepam or other benzodiazepines. Adverse Reactions: Drowsiness, fatigue, ataxia; risk of dependence with prolonged use. Nursing Responsibilities: Monitor vital signs during administration; assess for signs of misuse or dependence.

    Diazepam

  • 9

    Classification: Anticholinergic antiparkinsonian agent. Mechanism of Action: Blocks acetylcholine receptors in the CNS to reduce tremors and rigidity associated with Parkinson’s disease or drug-induced extrapyramidal symptoms. Indications: Parkinson’s disease management and acute dystonic reactions from antipsychotics . Contraindications: Narrow-angle glaucoma and prostatic hypertrophy . Adverse Reactions: Dry mouth, constipation, urinary retention . Nursing Responsibilities: Monitor for anticholinergic side effects; educate patients on hydration needs .

    Benztropine

  • 10

    Classification: Antihistamine. Mechanism of Action: Competes with histamine at H1 receptor sites to reduce allergy symptoms . Indications: Allergic reactions, motion sickness prevention, insomnia . Contraindications: Acute asthma attacks and hypersensitivity to diphenhydramine . Adverse Reactions: Drowsiness, dry mouth, blurred vision . Nursing Responsibilities: Assess sedation levels; advise against operating heavy machinery until effects are known .

    Diphenhydramine

  • 11

    Classification: Anticholinergic antiparkinsonian agent. Mechanism of Action: Reduces cholinergic activity in the CNS to alleviate tremors associated with Parkinson’s disease . Indications: Management of parkinsonian symptoms and drug-induced extrapyramidal symptoms . Contraindications: Glaucoma and myasthenia gravis . Adverse Reactions: Dry mouth, constipation, urinary retention . Nursing Responsibilities: Monitor for anticholinergic side effects; educate on dosage adjustments if adverse reactions occur .

    Trihexyphenidyl

  • 12

    Classification: Selective serotonin reuptake inhibitor (SSRI). Mechanism of Action: Inhibits serotonin reuptake in the brain to enhance mood regulation . Indications: Major depressive disorder, anxiety disorders (including OCD), PTSD . Contraindications: Concurrent use with MAO inhibitors or hypersensitivity to sertraline . Adverse Reactions: Nausea, insomnia, sexual dysfunction . Nursing Responsibilities: Monitor mood changes and suicidal ideation; assess for serotonin syndrome symptoms during treatment initiation .

    Sertraline

  • 13

    is a progressive neurological disorder characterized by the degeneration of dopamine-producing neurons in the brain, leading to movement and mood disturbances.

    Parkinson’s disease

  • 14

    Parkinson’s disease: Typically starting in one hand or arm.

    Tremors

  • 15

    Parkinson’s disease: Slowed movements affecting daily tasks.

    Bradykinesia

  • 16

    Parkinson’s disease: Muscle stiffness impacting mobility and posture

    Rigidity